ARTAL GROUP S.A. – Cidara Therapeutics, Inc. Transaction History
ARTAL GROUP S.A. portfolio value:
$141,000
portfolio value
ARTAL GROUP S.A. quarter portfolio value change:
+28.53%
quarter
Cidara Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 31K | $0.63 | 224.67K | |
| Q2 2022 | share | 0.00% | 0 shares | -77K | $0.49 | 224.67K | |
| Q1 2022 | share | 0.00% | 0 shares | -98K | $0.83 | 224.67K | |
| Q4 2021 | share | 0.00% | 0 shares | -218K | $1.29 | 224.67K | |
| Q3 2021 | share | 0.00% | 0 shares | 49K | $2.24 | 224.67K | |
| Q2 2021 | share | 0.00% | 0 shares | -144K | $2.02 | 224.67K | |
| Q1 2021 | share | 0.00% | 0 shares | 149K | $2.66 | 224.67K | |
| Q4 2020 | share | 0.00% | 0 shares | -191K | $2 | 224.67K | |
| Q3 2020 | share | Decrease | -5.00% | -11.82K shares | -233K | $2.85 | 224.67K |
| Q2 2020 | share | Increase | 0.00% | 236.5K shares | 873K | $3.69 | 236.5K |